Please turn JavaScript on
San Diego Business Journal icon

San Diego Business Journal

Want to know the latest news and articles posted on San Diego Business Journal?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: Just a moment...

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  3.1 / day

Message History

SAN DIEGO – CityMark is building a housing project in Serra Mesa, Dezi, that combines apartment flats and townhomes. “There’s so little new home production in the central area of San Diego. We’re just excited to be able to bring this to market,” said Russ Haley, CityMark managing partner. “We pride ourselves on finding infill, […]

Read full story
RANCHO SANTA FE – Longtime San Diego commercial real estate executive Dan Broderick has joined Forge Partners, based in Rancho Santa Fe, as principal and partner. Broderick spent 14 years on the brokerage side of Cushman & Wakefield, most recently as president of Americas Advisory and president of Capital Markets. “Frankly, I had always wanted […]

Read full story
If we asked you who works in San Diego’s top industries, what careers would top your list? Computer Science? Engineering? These degrees matter to our most visible sectors. However, degrees in interactive design, digital media, animation and human-centered design are all highly sought after in the tech and innovation sector and cross every major sector […]

Read full story
SAN DIEGO – In a nation where 95% of personal injury cases settle before trial, according to the Bureau of Justice, San Diego firm HHJ Trial Attorneys is taking a contrary approach. By aggressively litigating cases, the firm employs a trial-first strategy that has solidified its reputation regionally. Over its first five years, the firm […]

Read full story
SAN DIEGO – The market for targeted cancer treatments has exploded over the last two decades, accounting for nearly half of the oncology drugs approved by federal regulators since 1998. While precision oncology is expected to grow toward a mid-nine-figure market by 2030, pharmaceutical developers remain challenged to find ways to target and destroy cancer […]

Read full story